Wood, B., Wu, D., Crossley, B., Dai, Y., Williamson, D., Gawad, C., . . . Kirsch, I. (2018). Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL. Blood.
Chicago Stili AlıntıWood, Brent, et al. "Measurable Residual Disease Detection By High-throughput Sequencing Improves Risk Stratification for Pediatric B-ALL." Blood 2018.
MLA AlıntıWood, Brent, et al. "Measurable Residual Disease Detection By High-throughput Sequencing Improves Risk Stratification for Pediatric B-ALL." Blood 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..